Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens
収録刊行物
-
- Haematologica
-
Haematologica 106 (3), 894-898, 2020-06-04
Ferrata Storti Foundation (Haematologica)
